BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12909740)

  • 1. Angiogenesis and antiangiogenic strategies in pancreatic cancer.
    Fisher WE; Berger DH
    Int J Gastrointest Cancer; 2003; 33(1):79-88. PubMed ID: 12909740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic carcinogenesis: apoptosis and angiogenesis.
    Onizuka S; Kawakami S; Taniguchi K; Fujioka H; Miyashita K
    Pancreas; 2004 Apr; 28(3):317-9. PubMed ID: 15084979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia and angiogenesis in pancreatic cancer.
    Garcea G; Doucas H; Steward WP; Dennison AR; Berry DP
    ANZ J Surg; 2006 Sep; 76(9):830-42. PubMed ID: 16922908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The importance of angiogenesis in pancreatic cancer].
    Myśliwiec P; Dadan J
    Przegl Lek; 2009; 66(3):155-8. PubMed ID: 19689042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis in pancreatic cancer: current research status and clinical implications.
    Li S; Xu HX; Wu CT; Wang WQ; Jin W; Gao HL; Li H; Zhang SR; Xu JZ; Qi ZH; Ni QX; Yu XJ; Liu L
    Angiogenesis; 2019 Feb; 22(1):15-36. PubMed ID: 30168025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting angiogenesis in pancreatic cancer: rationale and pitfalls.
    Whipple C; Korc M
    Langenbecks Arch Surg; 2008 Nov; 393(6):901-10. PubMed ID: 18210149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenesis therapy in pancreatic carcinoma.
    Saif MW
    JOP; 2006 Mar; 7(2):163-73. PubMed ID: 16525200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of angiogenesis in neuroendocrine tumors.
    Teulé A; Casanovas O
    Target Oncol; 2012 Jun; 7(2):93-8. PubMed ID: 22592949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.
    Yuan P; Wang L; Wei D; Zhang J; Jia Z; Li Q; Le X; Wang H; Yao J; Xie K
    Cancer; 2007 Dec; 110(12):2682-90. PubMed ID: 17973266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic strategies in pancreatic cancer.
    Riess H
    Recent Results Cancer Res; 2008; 177():123-9. PubMed ID: 18084954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.
    Pietras K; Hanahan D
    J Clin Oncol; 2005 Feb; 23(5):939-52. PubMed ID: 15557593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors.
    Capozzi M; VON Arx C; DE Divitiis C; Ottaiano A; Tatangelo F; Romano GM; Tafuto S;
    Anticancer Res; 2016 Oct; 36(10):5025-5030. PubMed ID: 27798861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional anti-angiogenesis therapy of human pancreatic cancer.
    Xie K; Wei D; Huang S
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):147-56. PubMed ID: 16516532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma.
    Craven KE; Gore J; Korc M
    Cancer Lett; 2016 Oct; 381(1):201-10. PubMed ID: 26723874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model.
    Zhang X; Galardi E; Duquette M; Delic M; Lawler J; Parangi S
    Clin Cancer Res; 2005 Mar; 11(6):2337-44. PubMed ID: 15788685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.
    Samuel DP; Wen PY; Kieran MW
    Expert Opin Investig Drugs; 2009 Jul; 18(7):973-83. PubMed ID: 19548852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.
    Jia Z; Zhang J; Wei D; Wang L; Yuan P; Le X; Li Q; Yao J; Xie K
    Cancer Res; 2007 May; 67(10):4878-85. PubMed ID: 17510417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it].
    Klener P
    Klin Onkol; 2010; 23(1):14-20. PubMed ID: 20192069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived proangiogenic cells in pancreatic cancer.
    Mizukami Y
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():23-6. PubMed ID: 22320912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.